Summary and prospect of perioperative comprehensive treatment for gastric cancer in China
Journal Title: Journal of Surgery : Concepts & Practice - Year 2023, Vol 28, Issue 1
Abstract
Most of the patients with gastric cancer in China have been at the middle and advanced stages during diagnostic and treatment with poor prognosis overall. Perioperative radiotherapy, chemotherapy, immune therapy and other comprehensive treatment methods for gastric cancer patients preoperative and intraoperation may reduce tumor staging, increase the rate of surgical resection and prolong the time of patient survival. Perioperative comprehensive treatment has developed more than 30 years in China. Many results from relevant research were gotten combined with laying down the consensus and guidelines, and applied to clinic in recent years. With the emergence and development of new technologies and new strategies for comprehensive treatment, perioperative comprehensive treatment and conversion therapy will improve at much extent the rate of survival for gastric cancer patients in China.
Authors and Affiliations
Wentao LIU, Fukun LIU
Keywords
Related Articles
- EP ID EP750841
- DOI 10.16139/j.1007-9610.2023.01.06
- Views 22
- Downloads 0
Bedside ultrasound diagnosis and risk factors of early thromboembolism after pancreaticoduodenectomy with vein reconstruction
[Objective] To investigate the risk factors of early thromboembolism after pancreaticoduodenectomy with vein reconstruction. [Methods] The results of bedside ultrasonography and clinical data of 90 patients from Ruijin H...
Application of advanced integrated two-stage laparoscopic simulation training course in standardized training of surgical residents
[Objective] To explore the feasibility and rationality of advanced integrated two-stage laparoscopic simulation training course in standardized training of surgical residents. [Methods] From December 2019 to December 202...
<![CDATA[Current status and future perspective of hepatic artery infusion chemotherapy]]>
<![CDATA[]]>
Progress and prospect of surgical comprehensive treatment of gastric cancer
Gastric cancer is one of the leading malignancies in China and in the world. Surgery is still the most important modality to cure gastric cancer. A series of clinical researches changed the traditional concept of surgery...
Systemic therapy alters the landscape of surgery in hepatocellular carcinomaļ¼ opportunities and challenges
Surgery is still the first choice for patients with hepatocellular carcinoma(HCC). However, about 70% of HCC patients in China are first diagnosed in the advanced stage and have lost the opportunity for surgery. Recently...